Document is current
Any future updates will be listed below
-
Authors
Belaunzarán-Zamudio, Pablo F. http://orcid.org/0000-0003-4775-4734
Rincón León, Héctor Armando
Caballero Sosa, Sandra
Ruiz, Emilia
Nájera Cancino, José Gabriel
de La Rosa, Paul Rodriguez
Guerrero Almeida, María de Lourdes
Powers, John H. III
Beigel, John H.
Hunsberger, Sally
Trujillo, Karina
Ramos, Pilar
Arteaga-Cabello, Fernando J.
López-Roblero, Alexander
Valdés-Salgado, Raydel
Arroyo-Figueroa, Hugo
Becerril, Eli
Ruiz-Palacios, Guillermo
,
Regalado Pineda, Justino
Rincón-León, Héctor Armando
Navarro-Fuentes, Karla R.
Caballero-Sosa, Sandra
Camas-Durán, Francisco
Priego-Smith, Zoyla
Ruiz, Emilia
Nájera-Cancino, José Gabriel
Rodriguez De la Rosa, Paul
Sepúlveda-Delgado, Jesús
Vera Maloof, Alfredo
Trujillo, Karina
López-Roblero, Alexander
Valdés-Salgado, Raydel
Bertucci, Yolanda
Trejos, Isabel
Villalobos, Luis Diego
Belaunzarán-Zamudio, Pablo F.
Ramos, Pilar
Arteaga-Cabello, Fernando J.
Guerrero, Lourdes
Ruiz-Palacios, Guillermo
Guerra Blas, Paola del Carmen
Mendoza-Garcés, Luis
Roy, Samira Toledo
Arroyo-Figueroa, Hugo
Quidgley, Peter
Macedo, Laura
Becerril, Eli
Montenegro Liendo, Abelardo
Powers, John H.
Beigel, John H.
Hunsberger, Sally
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02831699 at ClinicalTrials.govDocuments that mention this clinical trial
Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016–2018): an observational, prospective cohort study
https://doi.org/10.1186/s12879-021-06520-x
-
Funding
Funding for this research was provided by:
Consejo Nacional de Ciencia y Tecnología (71260, 127088)
National Institutes of Health (HHSN261200800001E, HHSN261201500003I)
- License Information
-
More Information
Article History
Received: 26 February 2020
Accepted: 2 August 2021
First Online: 28 August 2021
Declarations
:
: The study protocol was approved by an Institution Review Board in all participating institutions in Mexico. Signed informed consent was obtained from all subjects. Participation of minors (< 18 year old) was consented by their legal guardians and their verbal (< 8 year old) or written (8–17 year old) assent was requested. If subjects were not able to sign the consent form because of the severity of the disease, a legal representative was asked to sign the consent form. The study was reviewed and approved by the Comité de Ética en Investigación (Comittee on Ethics in Research) and the Comité de Investigación (Research Comittee) at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INF-2636-18-19-1) for implementation at the General Hospital of Tapachula City, Hospital Regional de Alta Especialidad Ciudad Salud, and Clínica Dr. Roberto Nettel Flores, ISSSTE. The protocol was reviewed and approved by the Comité de Ética en Investigación (Comittee on Ethics in Research) and the Comité de Investigación (Research Comittee) of the Instituto Mexicano del Seguro Social (Ref 09-B5-61-2800/201600/2378).
: Not applicable.
: Pablo-Belaunzarán Zamudio is an Associate Editor of BMC Infectious Diseases. The other authors declare that they have no competing interests.
